Home/Filings/4/0001213900-20-000985
4//SEC Filing

Kidron Miriam 4

Accession 0001213900-20-000985

CIK 0001176309other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:05 PM ET

Size

5.5 KB

Accession

0001213900-20-000985

Insider Transaction Report

Form 4
Period: 2020-01-08
Kidron Miriam
DirectorChief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-01-08+100,000100,000 total
    Exercise: $4.80Exp: 2030-01-08Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The Stock Option will vest in 4 installments as follows: 25,000 shall vest on each of December 31, 2020, December 31, 2021, December 31, 2022 and December 31, 2023.

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1
  • filerCIK 0001409232

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:05 PM ET
Size
5.5 KB